Dilated cardiomyopathy mutations in alpha-tropomyosin inhibit its movement during the ATPase cycle

Yurii S Borovikov1, Olga E Karpicheva, Galina A Chudakova

  • 1Laboratory of Mechanisms of Cell Motility, Institute of Cytology, Russian Academy of Sciences, 4 Tikhoretsky Avenue, 194064 St. Petersburg, Russia. boroviko@mail.cytspb.rssi.ru

Insights

Dilated cardiomyopathy (DCM) mutations in alpha-tropomyosin alter its position and actin affinity on muscle thin filaments. These structural changes explain reduced Ca2+-sensitivity and activation observed in DCM patients.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Dilated cardiomyopathy (DCM) is a severe heart condition.
  • Mutations in alpha-tropomyosin, specifically Glu40Lys and Glu54Lys, are linked to DCM.
  • These mutations impair cardiac muscle function by decreasing thin filament Ca2+-sensitivity.

Purpose of the Study:

  • To elucidate the molecular mechanisms behind the functional deficits caused by Glu40Lys and Glu54Lys alpha-tropomyosin mutations.
  • To correlate structural changes in tropomyosin with observed functional impairments in DCM.

Main Methods:

  • Labeling wild-type and mutant (Glu40Lys, Glu54Lys) alpha-tropomyosin with a fluorescent probe at Cys190.
  • Incorporating labeled tropomyosin into ghost muscle fibers.
  • Utilizing polarized fluorimetry to measure tropomyosin position on the thin filament and its actin affinity throughout the ATPase cycle.

Main Results:

  • Both DCM-associated mutations shifted tropomyosin towards the thin filament periphery.
  • Mutations altered tropomyosin's affinity for actin.
  • The amplitude of tropomyosin movement during the ATPase cycle was reduced, and in some stages, reversed.

Conclusions:

  • Structural alterations in tropomyosin, including altered position and actin binding, underlie the reduced Ca2+-sensitivity and activation in DCM.
  • These findings provide a molecular basis for understanding alpha-tropomyosin-linked dilated cardiomyopathy.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.